Regeneron Pharmaceuticals
REGN
REGN
1,159 hedge funds and large institutions have $66.1B invested in Regeneron Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 396 increasing their positions, 465 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,159
Holders Change
-27
Holders Change %
-2.28%
% of All Funds
18.28%
Holding in Top 10
28
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-33.33%
% of All Funds
0.44%
New
88
Increased
396
Reduced
465
Closed
107
Calls
$1.45B
Puts
$1.68B
Net Calls
-$229M
Net Calls Change
-$64.7M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
$2.12B |
| 2 |
JPMorgan Chase & Co
New York
|
$4.7B |
| 3 |
D.E. Shaw & Co
New York
|
$207M |
| 4 |
Man Group
London,
United Kingdom
|
$83.8M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
$80.6M |
Top Sellers
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
$45.1M |
| 2 |
BlackRock
New York
|
$6.53B |
| 3 |
Capital World Investors
Los Angeles,
California
|
$3.99B |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$6.59B |
| 5 |
Citadel Advisors
Miami,
Florida
|
$28.5M |
